Appendix Table 1.
Tests
|
||
---|---|---|
Test Characteristic | Colonoscopya | FITb |
| ||
Specificity, % | 0.86c | 0.964 |
Sensitivity, % | ||
Small adenomas (≤5mm) | 0.75 | 0.076d |
Medium adenomas (6-9 mm) | 0.85 | 0.076d |
Large adenomas (≥10 mm) | 0.95 | 0.238e |
CRCs that would not have been clinically detected in their current stage | 0.95 | 0.625f |
CRCs that would have been clinically detected in their current stage | 0.95 | 0.886f |
Reach | 95% reaches the cecum; the reach of the remaining 5% is distributed uniformly over colon and rectum | Whole colon and rectum |
Complication rate | Increases exponentially with ageg | 0 |
Mortality rate | 0.0000191h | 0 |
The sensitivity of colonoscopy for the detection of adenomas and CRC within the reach of the endoscope was obtained from a systematic review on miss rates seen in tandem colonoscopy studies33;
FIT characteristics were based on a large US based study comparing multi-targeted Stool DNA with FIT in a screening setting34;
Specificity for colonoscopy is therefore based on an adenoma prevalence study of patients undergoing screening colonoscopy36;
Sensitivity for non-advanced adenomas (not reported separately for medium adenomas);
Sensitivity for advanced adenomas (not reported for large adenomas);
These estimates were found by calibrating our model outcomes to the per-person sensitivities given in the multi-targeted Stool DNA with FIT 34;
Age-specific risks for complications of colonoscopy requiring a hospital admission or emergency department visit were obtained from a study by Warren et al37;